Juvenile nasopharyngeal angiofibroma

Cover Page

Cite item

Full Text

Abstract

Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that affects almost exclusively male adolescents. Usually, symptoms of JNA are detected within 15–24 months before seeking medical help. JNA is mainly diagnosed in patients aged 14 to 25 years. Angiofibroma consists of a complex mixture of blood vessels and a fibrous stroma. This feature of their structure determines the property of the tumor to bleed massively even after minimal surgical procedures. The tumor usually grows posteriorly and upward, involving the sphenoid sinus. Under certain circumstances, it can spread anteriorly into the nasal cavity with the involvement of ethmoid cells. With lateral spread, it affects the space of the pterygo-palatine fossa and can also spread into the infratemporal fossa through the expanded pterygo-maxillary fissure, into the region of the chewing muscles and soft tissues of the cheek. In this review, we briefly outline the study history, and current aspects of etiology, pathogenesis, diagnostic and treatment methods of JNA.

About the authors

A. S. Krasnov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation

Author for correspondence.
Email: alexey.s.krasnov@gmail.com
ORCID iD: 0000-0003-1099-9332

Alexey S. Krasnov, а researcher at the Department of Diagnostic Radiology

1 Samory Mashela St., Moscow 117997

Russian Federation

N. S. Grachev

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation

ORCID iD: 0000-0002-4451-3233
Moscow Russian Federation

I. N. Vorozhtsov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation

ORCID iD: 0000-0003-3986-3770
Moscow Russian Federation

G. V. Tereschenko

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology Ministry of Healthcare of Russian Federation

ORCID iD: 0000-0001-7317-7104
Moscow Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Krasnov A.S., Grachev N.S., Vorozhtsov I.N., Tereschenko G.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.